Pages that link to "Q37993908"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics (Q37993908):
Displaying 28 items.
- Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts (Q30421398) (← links)
- Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients (Q33829621) (← links)
- Single compartment drug delivery (Q34263907) (← links)
- Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer. (Q35032664) (← links)
- Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model (Q35777174) (← links)
- A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis (Q35868066) (← links)
- Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment (Q37309461) (← links)
- Nanocrystals for the parenteral delivery of poorly water-soluble drugs (Q38104343) (← links)
- Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models (Q38152303) (← links)
- Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. (Q38199370) (← links)
- Multifunctional platinum-based nanoparticles for biomedical applications (Q38812240) (← links)
- A model based analysis of IPEC dosing of paclitaxel in rats. (Q38993050) (← links)
- Uptake of Eudragit Retard L (Eudragit® RL) Nanoparticles by Human THP-1 Cell Line and Its Effects on Hematology and Erythrocyte Damage in Rats (Q39020781) (← links)
- Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer. (Q40379327) (← links)
- Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals (Q42321339) (← links)
- Pre-clinical evaluation of a themosensitive gel containing epothilone B and mTOR/Hsp90 targeted agents in an ovarian tumor model (Q47619786) (← links)
- Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer (Q47643972) (← links)
- High-Pressure Nebulization as Application Route for the Peritoneal Administration of siRNA Complexes (Q48762735) (← links)
- Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers (Q50245206) (← links)
- Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy. (Q53501359) (← links)
- Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer (Q57481603) (← links)
- Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2 (Q61807460) (← links)
- Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival (Q89285313) (← links)
- Surgical management of metastatic gastric cancer: moving beyond the guidelines (Q90321326) (← links)
- Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review (Q92140598) (← links)
- Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells (Q92358099) (← links)
- Modelling drug transport during intraperitoneal chemotherapy (Q92617950) (← links)
- Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer (Q98165145) (← links)